+49.6% since March: our AI-picked chipmaker keeps climbing after last week’s rout

Texas Instruments shares returned 49.56% from the AI model’s March 1, 2026 pick price of $208.94 through the Nov. 3 close; the stock gained 3.47% on Tuesday to $312.49. Q3 EPS of $2.62 beat the $2.42 consensus, while revenue of $6.06B beat $5.92B and rose 28% year over year; Q4 revenue guidance of $5.80B–$6.30B is above the $5.73B analyst average. TI raised its quarterly dividend 7% to $1.52 per share in September, marking its 23rd consecutive annual increase; eight analysts have also revised upcoming-period earnings estimates upward.

Analysis

The investable signal is a possible analog-chip recovery, not validation of the promotional AI-pick track record. Improving revenue and margins can drive outsized EPS through operating leverage, but the reported growth may be unusually easy to compare against a weak cycle; PEG based on near-term growth therefore risks overstating how inexpensive TXN is. After a sharp rerating and with the shares near their annual high, valuation leaves less room for a merely good quarter. The key question is whether demand broadens across industrial and automotive customers and supports sustained orders—not whether one quarter beats estimates.

Over the next 1–3 months, watch TXN’s next guidance, sequential revenue, gross-margin trajectory, and commentary on customer inventories and order trends. A reversal in any of these could unwind the earnings-growth premium; higher-for-longer rates would add pressure to a long-duration valuation. Over 6–18 months, capacity investment and utilization matter: if demand recovery lags added capacity, depreciation and fixed-cost absorption could constrain cash generation even while reported earnings look strong. Analog Devices, Microchip, NXP, and STMicroelectronics are relevant competitive read-throughs, but the article provides no comparative data to establish relative winners.

The contrarian point: strong execution is not the same as attractive forward risk/reward at the post-rally price. The article’s selected-stock returns are not evidence of repeatable excess returns and may reflect selection and survivorship effects. No fundamental short signal is established; avoid chasing until forward estimates and end-market demand confirm durability.

Key Decisions for Investors

• For existing TXN exposure, hold only against a defined review trigger; reassess if the next update shows sequential revenue deterioration, gross-margin reversal, or weaker guidance. The article does not support a numeric price target.
• For new capital, wait for either a pullback or another quarter confirming broad-based orders and margin durability rather than buying on the reported beat alone.
• A relative-value position in TXN versus Analog Devices is only a watch item: require current valuation, estimate-revision, and end-market comparisons before expressing the pair, since the supplied information does not establish which is cheaper or has stronger momentum.
• Treat a sustained decline in customer orders or inventory normalization taking longer than expected as the principal thesis-falsifier; stronger guidance and stable margins despite a weaker macro backdrop would strengthen the recovery case.